ClinicalTrials.govpublic full text
Study of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional Therapy
pathologically confirmed cancer refractory to conventional therapy, refractory cancer, metastatic cancer, recurrent cancer, solid tumor, adult, solid tumor, advanced cancer, advanced solid tumor, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 827379
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.